NCT05340569View on ClinicalTrials.gov

Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

March 30, 2024

Study Completion Date

September 30, 2024

Conditions
Pancreas Cancer, Duct Cell AdenocarcinomaPancreas AdenocarcinomaPeritoneal MetastasesPeritoneal Carcinomatosis
Interventions
DIAGNOSTIC_TEST

Whole-body diffusion-weighted magnetic resonance imaging

See arm description.

Trial Locations (1)

G1R 2J6

CHU de Québec, Québec

All Listed Sponsors
lead

Laval University

OTHER